A scientific paper entitled “The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumor Protein” was published in the International Journal of Molecular Sciences. Mirela Sedić, PhD, one of the authors of the paper, is from the Institute for Anthropological Research. This paper is the result of scientific research conducted within the project HRZZ IP-2018-01-3900 led by M. Sedić.
Access to paper via the following link: https://www.mdpi.com/1422-0067/22/19/10767/htm
